Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Philosys expects FDA approval for new Gmate blood glucose meter in Q3 2012

Philosys is looking forward for the US Food and Drug Administration (FDA) approval of its new Gmate blood glucose monitoring system in third quarter 2012.

By utilizing Smartphone technology, Gmate blood glucose meter works with the headphone connector of the iPhone, iPad and iPod.

Philosys operations manager Jennifer Kupar said the company is preparing to bring Gmate blood glucose meter to the US.

"Gmate is the perfect solution for diabetics seeking digital solutions to monitor their disease with the push of a button," Kupar added.

"We look forward to FDA approval of our revolutionary device this year."